SWOT Analysis Report of Biochips Market in North America
TechNavio recognizes the following companies as the key players in - Biochips Market in North America: Affymetrix Inc., Agilent Technologies Inc., Illumina Inc., Life Technologies Corp., and Roche Holding AG.
Over the years, a large number of drug manufacturers have been outsourcing their drug development processes to contract research organizations. Outsourcing activities reduce manufacturing and distribution costs, ensure quality of service, and reduce lead time. They also help the sourcing companies manage product demand and concentrate on other competencies such as innovation and brand building. These contract research organizations employ the latest technologies and sophisticated instruments, and thus increased outsourcing to such organizations is a positive trend driving the market.
Complete report is spread across 63 pages is available @ http://www.reportsnreports.com/reports/273329-biochips-market-in-north-america-2014-2018-.html.
The analysts forecast the Biochips market in North America to grow at a CAGR of 10.24 percent over the period 2013-2018.According to the report, one of the main drivers of this market is the increased need for high-speed diagnosis for patients and doctors. Biochips are specially designed with advanced technology that makes them ultra-efficient, thus enhancing their operating speed to a great extent.
The report, the Biochips Market in North America 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on North America; it also covers the Biochips market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The report recognizes the following companies as the key players in - Biochips Market in North America: Affymetrix Inc., Agilent Technologies Inc., Illumina Inc., Life Technologies Corp., and Roche Holding AG.
Key questions answered in this report:
• What will the
Over the years, a large number of drug manufacturers have been outsourcing their drug development processes to contract research organizations. Outsourcing activities reduce manufacturing and distribution costs, ensure quality of service, and reduce lead time. They also help the sourcing companies manage product demand and concentrate on other competencies such as innovation and brand building. These contract research organizations employ the latest technologies and sophisticated instruments, and thus increased outsourcing to such organizations is a positive trend driving the market.
Complete report is spread across 63 pages is available @ http://www.reportsnreports.com/reports/273329-biochips-market-in-north-america-2014-2018-.html.
The analysts forecast the Biochips market in North America to grow at a CAGR of 10.24 percent over the period 2013-2018.According to the report, one of the main drivers of this market is the increased need for high-speed diagnosis for patients and doctors. Biochips are specially designed with advanced technology that makes them ultra-efficient, thus enhancing their operating speed to a great extent.
The report, the Biochips Market in North America 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on North America; it also covers the Biochips market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The report recognizes the following companies as the key players in - Biochips Market in North America: Affymetrix Inc., Agilent Technologies Inc., Illumina Inc., Life Technologies Corp., and Roche Holding AG.
Key questions answered in this report:
• What will the